Effect of the
B lymphocyte
Chagas disease
excretory–secretory antigen
immune evasion
trans-sialidase
Journal
Parasitology
ISSN: 1469-8161
Titre abrégé: Parasitology
Pays: England
ID NLM: 0401121
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
30
5
2020
medline:
10
4
2021
entrez:
30
5
2020
Statut:
ppublish
Résumé
Trypanosoma cruzi, the etiological agent of Chagas disease, releases factors, including antigens from the trans-sialidase (TS) superfamily, which modulate the host immune responses. Tc13 antigens belong to group IV of TSs and are characterized by C-terminal EPKSA repeats. Here, we studied the effect of the Tc13 antigen from the Tulahuén strain, Tc13Tul, on primary cultures of splenocytes from naïve BALB/c mice. Recombinant Tc13Tul increased the percentage of viable cells and induced B (CD19+) lymphocyte proliferation. Tc13Tul stimulation also induced secretion of non-specific IgM and interferon-γ (IFN-γ). The same effects were induced by Tc13Tul on splenocytes from naïve C3H/HeJ mice. In vivo administration of Tc13Tul to naïve BALB/c mice increased non-specific IgG in sera. In addition, in vitro cultured splenocytes from Tc13Tul-inoculated mice secreted a higher basal level of non-specific IgM than controls and the in vitro Tc13Tul stimulation of these cells showed an enhanced effect on IgM and IFN-γ secretion. Our results indicate that Tc13Tul may participate in the early immunity in T. cruzi infection by favouring immune system evasion through B-cell activation and non-specific Ig secretion. In contrast, as IFN-γ is an important factor involved in T. cruzi resistance, this may be considered a Tc13Tul effect in favour of the host.
Identifiants
pubmed: 32466805
doi: 10.1017/S0031182020000864
pii: S0031182020000864
pmc: PMC10317719
doi:
Substances chimiques
Antigens, Protozoan
0
Glycoproteins
0
Immunoglobulin G
0
Recombinant Proteins
0
trans-sialidase
EC 3.2.1.-
Neuraminidase
EC 3.2.1.18
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1114-1123Références
Infect Immun. 1999 Aug;67(8):3864-71
pubmed: 10417150
Exp Parasitol. 2003 Mar-Apr;103(3-4):112-9
pubmed: 12880587
Parasitology. 2006 Jun;132(Pt 6):855-66
pubmed: 16478565
PLoS One. 2013;8(2):e57450
pubmed: 23437390
J Infect Dis. 1999 Oct;180(4):1398-402
pubmed: 10479182
Parasitology. 2008 Mar;135(3):347-57
pubmed: 17991305
PLoS Negl Trop Dis. 2010 Jul 06;4(7):e733
pubmed: 20625554
J Clin Microbiol. 1994 Apr;32(4):971-4
pubmed: 8027352
Immunology. 2011 Jan;132(1):123-33
pubmed: 20875075
J Infect Dis. 1998 Feb;177(2):431-6
pubmed: 9466532
Mol Cell. 2002 Oct;10(4):757-68
pubmed: 12419220
Nat Med. 2000 Aug;6(8):890-7
pubmed: 10932226
Infect Immun. 2014 Sep;82(9):3687-96
pubmed: 24935974
Cell Microbiol. 2006 Jul;8(7):1086-95
pubmed: 16819962
J Immunol. 2002 May 15;168(10):5192-8
pubmed: 11994475
J Leukoc Biol. 2019 May;105(5):843-856
pubmed: 30457676
Int Immunol. 2002 Mar;14(3):299-308
pubmed: 11867566
Cell Res. 2014 Feb;24(2):161-76
pubmed: 24296781
Immunology. 1998 Jun;94(2):189-96
pubmed: 9741340
FEMS Microbiol Lett. 2000 Aug 15;189(2):253-7
pubmed: 10930747
Gene. 1995 Jul 4;160(1):123-8
pubmed: 7628705
PLoS Pathog. 2006 Aug;2(8):e77
pubmed: 16879036
PLoS One. 2013;8(3):e58967
pubmed: 23536842
Trends Parasitol. 2017 Feb;33(2):102-112
pubmed: 27843019
PLoS Pathog. 2010 Apr 29;6(4):e1000870
pubmed: 20442858
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
Infect Immun. 1996 Jan;64(1):128-34
pubmed: 8557330
Glycobiology. 1999 Jun;9(6):581-7
pubmed: 10336990
Eur J Immunol. 1992 Oct;22(10):2501-6
pubmed: 1396957
J Immunol. 2000 Aug 1;165(3):1331-6
pubmed: 10903734
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
J Immunol. 1999 May 15;162(10):6092-9
pubmed: 10229851
Infect Immun. 2005 Jan;73(1):181-92
pubmed: 15618153
Cancer Res. 1960 May;20:462-6
pubmed: 14427849
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
Diagn Microbiol Infect Dis. 2013 Jun;76(2):197-205
pubmed: 23537784
Scand J Immunol. 1988 Nov;28(5):553-61
pubmed: 2463663
Int Immunopharmacol. 2017 Sep;50:338-344
pubmed: 28750349
Mol Biochem Parasitol. 1989 May 15;34(3):221-8
pubmed: 2499788
J Immunol. 1994 Oct 1;153(7):3148-54
pubmed: 7522250
Indian J Crit Care Med. 2009 Apr-Jun;13(2):49-53
pubmed: 19881183
Parasitol Today. 1992 Nov;8(11):378-81
pubmed: 15463546
Blood. 1999 Mar 15;93(6):2025-32
pubmed: 10068675
J Immunol. 1992 Dec 1;149(11):3753-8
pubmed: 1385530
J Control Release. 2016 Oct 10;239:107-17
pubmed: 27574990
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1239-43
pubmed: 1371355
J Immunol. 2002 Jun 15;168(12):6366-74
pubmed: 12055254
Infect Immun. 2008 Feb;76(2):750-8
pubmed: 18070905
PLoS One. 2011;6(10):e25914
pubmed: 22039427
Infect Immun. 2001 Dec;69(12):7946-9
pubmed: 11705983
Glycobiology. 2004 Nov;14(11):53R-62R
pubmed: 15229195
Front Immunol. 2016 Jan 18;6:659
pubmed: 26834737
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
J Exp Med. 1978 Jun 1;147(6):1744-54
pubmed: 308089
Nat Immunol. 2013 May;14(5):514-22
pubmed: 23563688
J Biol Chem. 2004 Feb 13;279(7):5323-8
pubmed: 14634017
J Biol Chem. 2002 Nov 29;277(48):45962-8
pubmed: 12237289